Apkarian, Apkar Vania
- Northwestern University · Physiology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #16,653
- Sustained Excellence
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Physiology
NIH Funding · FY2023
Linked Award Amount
$689.8K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#16,653
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Apkarian, Apkar Vania as a PI. Multi-PI records show the full award amount for context.
- 5R01AR074274-05R01Contact PIBrain Pathophysiology of Osteoarthritis PainNorthwestern University · Physiology (NIH department code)$689.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Apkarian, Apkar Vania as a PI.
FY2023 award administered by Northwestern University (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardNorthwestern University
- 2006$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2008Entered Top 50% NationallyRanked #6767
- 2009$2M Cumulative Funding
- 2012$5M Cumulative Funding
- 2012Entered Top 25% NationallyRanked #3398
- 2012R01 Grant Holder
- 2014$10M Cumulative Funding
- 2020Entered Top 10% NationallyRanked #609
- 2020Entered Top 5% NationallyRanked #609
- 2022$25M Cumulative Funding